BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2981514)

  • 1. [Serum neuron-specific enolase as a marker of lung cancers].
    Fujisawa T; Yamaguchi Y; Sasaki K; Fukazawa T; Hongo H; Ogawa T; Kimura H
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):139-43. PubMed ID: 2981514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of serum NSE and CEA in primary lung cancer patients].
    Fukasawa T; Fujisawa T; Yamaguchi Y; Sasaki K; Shiba M; Yusa T; Sakio H; Momiki S; Ogawa T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1862-7. PubMed ID: 3010884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer].
    Yumoto Y; Shiota T; Tamai M; Okabe K; Kiura K; Shimoe T; Fujii M
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2089-93. PubMed ID: 3013098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
    Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical investigation of neuron-specific enolase, squamous cell carcinoma-related antigen and carcinoembryonic antigen in carcinoma of the lung].
    Tashiro T; Nagai H; Yamasaki H; Kuroda Y; Goto Y; Goto J; Nasu M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2383-8. PubMed ID: 3015044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
    Shibayama T; Ohnoshi T; Ueoka H; Horiguchi T; Kodani T; Segawa Y; Maeda T; Miyatake K; Takigawa N; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of neuron-specific enolase as a new tumor marker for carcinoma of the lung].
    Ariyoshi Y
    Gan No Rinsho; 1984 May; 30(6 Suppl):569-73. PubMed ID: 6086970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The simultaneous evaluation of serum NSE as a tumor marker in lung cancer compared with serum CEA--high sensitivity and specificity defined in the TP-FP curve].
    Shimizu K; Nose I; Koga T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):472-8. PubMed ID: 3006595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
    Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R
    Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study].
    Leonardo E; Dogliotti C; Oliaro A
    Minerva Med; 1986 May; 77(22-23):977-80. PubMed ID: 3014380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma].
    Gasser RW; Herold M; Müller-Holzner E; Müller LC; Salzer GM; Huber H
    Dtsch Med Wochenschr; 1988 Nov; 113(44):1708-13. PubMed ID: 2846253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
    Kawachi S; Shimabukuro Z; Aoyama A; Yano T; Hasegawa K; Tsuboi E; Niitani H
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2469-74. PubMed ID: 3039919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
    Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K; Påhlman S
    Anticancer Res; 1989; 9(6):1717-20. PubMed ID: 2560624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
    Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M
    Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
    Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC.
    Ebert W; Muley T; Trainer C; Dienemann H; Drings P
    Anticancer Res; 2002; 22(2B):1083-9. PubMed ID: 12168905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.